VANCOUVER – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), an end-to-end drug researcher and formulator licensed by Health Canada to produce...
VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) — MindBio Therapeutics (CSE:MBIO), through its scientific... The post MULTIMEDIA UPDATE –...
MindBio clinical trial published in Peer Reviewed Paper Biological Psychiatry First of 8 significant publications on LSD-Microdosing from a Phase 1 clinical...
The article Which Psychedelic Medicine Companies Have the Best Financials? was originally published on Microdose. As I have written many times before,...
The mushroom cultivator will be supplying a private client for clinical research purposes The post Optimi Health enters $1.2M psilocybin distribution...
The article Albert Labs Receives Acceptance of 35 Patent Claims for Manufacturing Technology was originally published on Microdose. Albert Labs Receives...
The Amanita muscaria extract was the subject of research published last month in Frontiers in Pharmacology The post Psyched Wellness extract shows positive...
The article Albert Labs Receives Acceptance of 35 Novel Patent Claims for Manufacturing Technology was originally published on Microdose. Albert Labs...
KETARX is an injectable ketamine formulation to treat a symptom of Parkinson's. The post PharmaTher Asks FDA to Fast Track Ketamine Drug for Parkinson’s...
The study showed how mushroom extracts could boost immune cells in the brain. The post Psyched Wellness Releases Positive Amanita Mushroom Study appeared...